Amgen’s Otezla, Repatha and biosimilars put on notice, with challenging years ahead aliu Mon, 11/22/2021 – 11:19
Category: Uncategorized
According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), convolutional neural networks (CNN) […]
Godlee touches on the often overlooked issues of dissent, resistance, incivility, and indeed rebellion in relation to health.1 […]
A hospital trust has been fined more than £2.5m after pleading guilty to failing to provide safe care […]
The United States’ opioid epidemic worsened significantly during the pandemic, with overdose deaths recorded in the 12 months […]
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working? nmissakian Fri, 11/19/2021 – […]
FDA asks for 55 years to complete FOIA request on Pfizer’s COVID-19 vaccine fkansteiner Fri, 11/19/2021 – 15:22
Recently the US National Library of Medicine (NLM) unveiled new terms to be included in the medical subject […]
Abstract:Healthcare involves tackling patients’ problems using many different types of resources, both human and technological, and the spaces […]
